TTC7B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.791200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.695200E-01
Normal-vs-Stage2
1.227430E-04
Normal-vs-Stage3
2.004100E-02
Normal-vs-Stage4
3.584000E-01
Stage1-vs-Stage2
7.924400E-01
Stage1-vs-Stage3
4.713200E-01
Stage1-vs-Stage4
8.954600E-01
Stage2-vs-Stage3
4.534600E-01
Stage2-vs-Stage4
9.976400E-01
Stage3-vs-Stage4
6.151400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.563100E-04
Normal-vs-AfricanAmerican
9.056300E-02
Normal-vs-Asian
4.480300E-02
Caucasian-vs-AfricanAmerican
8.137800E-01
Caucasian-vs-Asian
3.905600E-01
AfricanAmerican-vs-Asian
6.813000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.048100E-04
Normal-vs-Female
5.938800E-03
Male-vs-Female
3.104200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.562400E-01
Normal-vs-Age(41-60Yrs)
7.409600E-02
Normal-vs-Age(61-80Yrs)
2.778300E-04
Normal-vs-Age(81-100Yrs)
2.904800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.948800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.450000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.878380E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.577950E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.072100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.547400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.559800E-02
Normal-vs-Daily Drinker
1.150130E-02
Normal-vs-Weekly Drinker
4.992800E-01
Normal-vs-Occasional Drinker
1.535440E-01
Normal-vs-Social Drinker
8.816000E-01
Non Drinker-vs-Daily Drinker
1.403960E-01
Non Drinker-vs-Weekly Drinker
6.454000E-02
Non Drinker-vs-Occasional Drinker
1.916250E-01
Non Drinker-vs-Social Drinker
7.946000E-02
Daily Drinker-vs-Weekly Drinker
3.377800E-01
Daily Drinker-vs-Occasional Drinker
7.641200E-01
Daily Drinker-vs-Social Drinker
3.004000E-01
Weekly Drinker-vs-Occasional Drinker
5.979400E-01
Weekly Drinker-vs-Social Drinker
7.696600E-01
Occasional Drinker-vs-Social Drinker
4.454800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.215800E-01
Normal-vs-Grade 2
7.891400E-01
Normal-vs-Grade 3
7.443600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.881950E-01
Grade 1-vs-Grade 3
8.988000E-02
Grade 1-vs-Grade 4
9.215800E-01
Grade 2-vs-Grade 3
2.573000E-01
Grade 2-vs-Grade 4
7.891400E-01
Grade 3-vs-Grade 4
7.443600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.197400E-03
Normal-vs-NonDiabetic
2.000600E-03
Diabetic-vs-NonDiabetic
7.646600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.473640E-01
Normal-vs-NoPancreatitis
1.401930E-03
Pancreatitis-vs-NoPancreatitis
7.132000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.556300E-02
Normal-vs-N1
1.569030E-04
N0-vs-N1
4.586400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.988210E-02
Normal-vs-TP53-NonMutant
8.732000E-02
TP53-Mutant-vs-TP53-NonMutant
3.037200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
